Study of the analgesic efficacy of stellate ganglion blockade in the management of the complex regional pain syndrome in patients with pain mediated by sympathetic nervous system: Preliminary study;Determinación de la eficacia analgésica de los bloqueos del ganglio estrellado en el síndrome doloroso regional complejo con dolor mediado por el sistema nervioso simpático: Estudio preliminar

Revista de la Sociedad Espanola del Dolor

Volumn 13, Issue 4, 2006, Pages 230-237

  Rodríguez, René F ^a   Bravo, L E ^b   Tovar, M A ^b   Castro, F ^c   Ramos, G E ^a   Daza, P ^a  

^a UNIVERSIDAD LIBRE   (Colombia)

^b UNIVERSIDAD DEL VALLE   (Colombia)

^c Clínica para Alivio del Dolor Y Cuidados Paliativos ISS   (Colombia)

Author keywords

Causalgia; Complex regional pain syndrome; Pain; Reflex sympathetic dystrophy; Relief of pain; Sympathetic blockade; Sympathetic pain

Indexed keywords

ANALGESIC AGENT;

ADRENERGIC SYSTEM; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLEX REGIONAL PAIN SYNDROME; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOMINANCE BEHAVIOR; DRUG EFFICACY; EDUCATION; HUMAN; PHYSIOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SINGLE BLIND PROCEDURE; SMOKING; STATISTICAL ANALYSIS; STELLATE GANGLION BLOCK;

EID: 33751503538     PISSN: 11348046     EISSN: 11348046     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. De Vet HCW, de Bie RA, Verhagen AP, et al. Systematic reviews on the basis of methodological criteria. Physiotherapy, 1997; 83:284-289.
2. Forouzanfar T, Koke A, Kleef M, et al. Treatment of complex regional pain syndrome type I. European Journal of Pain, 2002; 6:105-122.
3. Harden RN, Bruehl S, Galer BS, et al. Complex regional pain syndrome: Are the IASP diagnostic criteria valid and sufficiently comprehensive? Pain, 1999; 83:211-221.
4. Oerlemans HM, Cup HE, Goris AR. Construction and reability in patients with reflex sympathetic dystrophy of one upper extremity. Disability and Rehabilitation, 2000; 5:233-45.
5. Roberts WJ. A hypothesis on the physiologic basic for causalgia and related pains. Pain, 1986; 24:297-311.
6. Cepeda S. Síndrome doloroso regional complejo tipos I-II. En Rodríguez RF. Medicina del dolor y cuidados paliativos. Editorial Universidad Libre. Cali, 1998; 71-79.
7. Baron R. Peripheral neuropathic pain: from mechanisms to symptoms. Clin J Pain, 2000; 16:S12-S20.
8. Woolf CJ, Mannion RJ. Neuropathic pain: etiology, symptoms, mechanisms, and management. Lancet, 1999; 353:1959-64.
9. Backonja M, Gombar K. Serum lidocaine levels following stellate ganglion sympathetic blocks and intravenous lidocaine injection. J Pain Symptom Manage, 1992; 7:2-3.
10. Buckley FP. Regional Anesthesia with Local Anesthetics. En Bonica's Management of Pain. J Loeser Editor. Lippincott Williams and Williams. Seattle, pp. 1930-1933.
11. Price DD, Long S, Wilsey B, et al. Analysis of peak magnitude and duration of analgesia produced by local anesthetics injected into sympathetic ganglia of complex regional pain syndrome patients. Clin J Pain 1998; 14:216-226.
12. Jadad AR, Carroll D, Glynn CJ, et al. Intravenous regional sympathetic blockade for pain relief in reflex sympathetic dystrophy: a systematic review and a randomized, double-blind crossover study. J Pain Symptom Manage, 1995; 10:13-20.
13. Bonelli S, Conoscente F, Movilia PG, et al. Regional intravenous guanethidine vs. stellate ganglion block in reflex sympathetic dystrophies: a randomized trial. Pain, 1983; 16:297-307.
14. Gschwind C, Fricker R, Lacher G, et al. Does perioperative guanethidine prevent reflex sympathetic dystrophy? J Hand Surg, 1995; 20:773-775.
15. Christensen K, Jensen EM, Noer I. The reflex dystrophy syndrome response to treatment with systemic corticosteroids. Acta Chir Scand, 1982; 148:653-655.
16. Kemler MA, Barendse GA, van Kleef M, et al. Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. N Engl J Med, 2000; 343:618-624.
17. Gobelet C, Meier JL, Schaffner W, et al. Calcitonin and reflex sympathetic dystrophy syndrome. Clin Rheumatol 1986; 5:382-388.
18. Gobelet C, Waldburger M, Meier JL. The effect of adding calcitonin to physical treatment on reflex sympathetic dystrophy. Pain, 1992; 48:171-175.
19. Rauck RL, Eisenach JC, Jackson K, et al. Epidural clonidine treatment for refractory reflex sympathetic dystrophy [see comments]. Anesthesiology, 1993; 79:1163-1169.
20. Kettler RE, Abram SE. Intravenous regional droperidol in the management of reflex sympathetic dystrophy: a double-blind, placebo-controlled, crossover study. Anesthesiology, 1988; 69:933-936.
21. Rocco AG, Kaul AF, Reisman RM, et al. A comparison of regional intravenous guanethidine and reserpine in reflex sympathetic dystrophy. A controlled, randomized, double-blind crossover study. Clin J Pain, 1989; 5:205-209.
22. Fialka V, Resch KL, Ritter-Dietrich D, et al. Acupuncture for reflex sympathetic dystrophy [letter]. Arch Intern Med, 1993; 153:661, 665.
23. Oerlemans HM, Goris JA, de Boo T, et al. Do physical therapy and occupational therapy reduce the impairment percentage in reflex sympathetic dystrophy? Am J Phys Med Rehabil. 1999; 78:533-539.
24. Wallace MS, Ridgeway BM, Leung AY, et al. Concentration-effect relationship of intravenous lidocaine on the allodynia of complex regional pain syndrome types I and II. Anesthesiology, 2000; 92:75-83.
25. Dellemijn PJI, Fields HL, Allen RR, et al. The interpretation of pain relief and sensory changes following sympathetic block. Brain, 1994; 17:1475-1487.
26. Díaz PA, Plancarte R, Tamayo A. Síndrome doloroso regional complejo. Estado actual. Cir Ciruj, 2004; 72:225-238.
27. Cepeda S, Lau J, Carr D. Defining the therapeutic role of local anesthetic sympathetic blockade in Complex Regional Pain Syndrome: A Narrative and systematic Review. The Clinical Journal of Pain, 2002; 18:216-33.
28. Mitzy F. Reinders MF, Geertzen JH, et al. Complex Regional Pain Syndrome: Use of the International Association for the Study of Pain Diagnostic Criteria Defined in 1994. Clinical Journal of Pain, 2002; 18 N4.
29. Gómez M. Historia clínica del dolor: Clasificación, evaluación y prevalencia. En Gómez M. Medicina Paliativa en la Cultura Latinoamericana. Editorial Arán. Madrid, p. 474.
30. Galer BS, Schwartz L, Allen RJ. Complex regional Pain Syndromes Type I: Reflex Sympathetic Distrophy, and Type II: Causalgia. En Bonica's Management of Pain. J Loeser Editor. Lippincott Williams and Williams. Seattle, pp. 1930-1933.
31. Dennis R. Cómo estimar el tamaño de la muestra en investigaciones con humanos. En Llanos G. Epidemiología. Editorial Universidad Libre. Cali, 1998; pp. 92-9.
32. Veldman PH, Reynen HM, Arntz IE, et al. Signs and Symptoms of reflex sympathetic distrophy: prospective study of 829 patients. Lancet, 1993; 342:1012-1016.
33. Janig W. The puzzle of "reflex sympathetic dystrophy": mechanisms, hypothesis, open questions. In Janig W, Stanton-Hicks M, eds. Reflex sympathetic dystrophy: a reappraisal. Seattle, IASP Press, 1996; pp. 1-24.
34. Allen G, Galer BSSchwartz L. Epidemiology of complex regional pain syndrome: a retrospective chart review of 134 patients. Pain, 1999; 80:539-544.
35. Kingery WS. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain, 1997; 73:123-139.
36. Allen G, Galer BS, Schwartz L. Epidemiological review of 134 patients with complex pain syndrome assessed in a chronic pain clinic. Pain, 1999; 80:539-544.
37. Hogan QH, Abram SE. Neural blockade for diagnosis and prognosis: a review. Anesthesiology, 1997; 86:216-241.
38. Figuerola ML, Levin G, Bertotti A, et al. Normal sympathetic nervous system response in reflex sympathetic dystrophy. Funct Neurol, 2002; 17:77-81.
39. Oliver WV, Rowland MA, Marasco SF. Complex regional pain syndrome and methionine -Enkephalin-. Clinical Chemistry, 2006; 52:535.
40. Winnie AP. Differential Neural Blockade for the Diagnosis of Pain Mechanisms. In: Walkman SD, Winnie AP. Interventional Pain Management. Dannemiller Memorial Educational Foundation, Philadelphia, 1996; p. 135.